Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi

Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents,

Published: 2026-06-05